Close

Alexion Pharma (ALXN) Completes Asfotase Alfa BLA Rolling Submission

December 30, 2014 6:31 AM EST Send to a Friend
Alexion Pharma (NASDAQ: ALXN) announced completion of the rolling submission of a Biologics License Application (BLA) to the U.S. Food ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login